Concepedia

Author

François Mach

University Hospital of GenevaORCID

Also Known As

Christian Müller, Elina Hyppönen , F M Mach, F MACH, F Mach, F. MACH, F. Mach, F.M Mach, F.M. Mach, FRANCOIS MACH

741

Publications

44.7K

Citations

96

H-Index

184

Concepts

All Affiliations

University Hospital of GenevaUniversity of GenevaUniversity of GenoaUniversity Hospital of BernFoundation for laboratory medicine
FM

About

François Mach is an author at University Hospital of Geneva specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

43

95

12K

2

Public Health

20

26

4K

3

Health Sciences

10

11

367

4

Social Sciences

3

3

503

5

Engineering

2

2

34

François Mach

×

257

Publications

28K

Citations

82

H-Index

YearCitations

Rosuvastatin in Older Patients with Systolic Heart Failure

John Kjekshus, Eduard Apetrei, Vivencio Barrios,

New England Journal of Medicine

2007

1.5K

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes,

European Heart Journal

2022

1.1K

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

François Mach, Uwe Schönbeck, Galina K. Sukhova,

Nature

1998

912

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano,

Circulation

2019

895

Common variants associated with plasma triglycerides and risk for coronary artery disease

Ron Do, Cristen J. Willer, Ellen M. Schmidt,

Nature Genetics

2013

890

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni,

The Lancet

2018

761

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis

François Mach, Uwe Schönbeck, Galina K. Sukhova,

Proceedings of the National Academy of Sciences

1997

734

Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Uwe Schönbeck, François Mach, Peter Libby

PubMed

1998

682

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Robert P. Giugliano, Terje R. Pedersen, Jeong-Gun Park,

The Lancet

2017

658

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

Reijo Laaksonen, Kim Ekroos, Marko Sysi‐Aho,

European Heart Journal

2016

655

Page 1